Top Markets
#1 Fake World Assets Fake World Assets +11.84%
#2 TENDIES TENDIES +6.51%
#3 Janction Janction +5.07%
#4 GoPlus Security GoPlus Security +4.45%
#5 B3 (Base) B3 (Base) +4.30%
#6 Status Status +4.24%
#7 Everything Everything +3.72%
#8 TronBank TronBank +3.26%
#9 Cross Cross +2.99%
#10 Tutorial Tutorial +2.63%
Coin of the day
Fake World Assets Fake World Assets
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Kineta, Inc. Kineta, Inc.

Kineta, Inc.

KA
Classificação em ações #34153
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing... Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
Preço da ação
$0.617
Última sincronização: 2024-10-14
Valor de mercado
$6.13M
Variação (1 dia)
0.49%
Variação (1 ano)
0.00%
País
US
Negociar Kineta, Inc. (KA)

Categoria

Healthcare
Rácio P/B de Kineta, Inc. (KA)
Rácio P/B em August 2026 TTM: -0.58
De acordo com os relatórios financeiros mais recentes e o preço das ações da Kineta, Inc., o rácio P/B atual (TTM) é -0.58. No final de 2023, o rácio P/B era 13.88.
Histórico do rácio P/B da Kineta, Inc. de 2015 a 2026
Rácio P/B no final de cada ano
Ano Rácio P/B Alterar
2026 (TTM) -0.58 -6.79%
2024 -0.62 -104.47%
2023 13.88 96.37%
2022 7.07 -463.47%
2021 -1.95 36.18%
2020 -1.43 -198.50%
2019 1.45 71.37%
2018 0.85 -49.33%
2017 1.67 -23.75%
2016 2.19 -92.84%
2015 30.60 0.00%
Rácio P/B de empresas semelhantes ou concorrentes
Empresa Rácio P/B Diferença do rácio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -1,197.40%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -1,180.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -698.93%
BE